Roche's Gazyva/Gazyvaro Sbla For SLE Accepted By FDA; Decision Slated For December 2026 RTT News 12:04 Tue, 21 Apr
Correcting and replacing FDA Accepts Application for Genentech’s Gazyva for the Treatment of the Most Common Form of Lupus Business Wire (Press Release) 07:53 Tue, 21 Apr
Safety concerns continue to plague Roche’s BTK inhibitor in RMS Clinical Trials Arena 08:57 Thu, 23 Apr BTK Pharma All sources
FDA kicks off review of Roche's Gazyva for wider lupus use pharmaphorum 11:30 Tue, 21 Apr Gazyva FDA Pharma All sources
Roche confident despite strong Swiss franc, threat of generics ShareCast 12:05 Thu, 23 Apr Switzerland Pharma Currency Markets Article paywall
STAT Plus: With successful trials, Roche takes its MS drug to regulators, but safety questions loom STAT 00:22 Wed, 22 Apr Multiple Sclerosis Pharma Drugs and Alcohol
What to know about federal court ruling blocking mailing of widely used abortion pill PBS Online 2d Mifepristone US Pharma All sources
Is your baby formula safe? FDA’s largest study released The Dallas Express 1d Texas Business Texas All sources
FDA approves first non-antipsychotic drug for Alzheimer's agitation Medpage Today 3d Alzheimer's Health Pharma All sources
